Literature DB >> 11558496

Oncolytic viral anti-cancer therapy: a magic bullet?

J Bradbury.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11558496     DOI： 10.1016/S0140-6736(05)71407-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Tumor control in a model of bone marrow transplantation and acute liver-infiltrating B-cell lymphoma: an unpredicted novel function of cytomegalovirus.

Authors:  Katja C Erlach; Jürgen Podlech; Aysel Rojan; Matthias J Reddehase
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

2.  Mechanism of tumor remission by cytomegalovirus in a murine lymphoma model: evidence for involvement of virally induced cellular interleukin-15.

Authors:  Katja C Erlach; Matthias J Reddehase; Jürgen Podlech
Journal:  Med Microbiol Immunol       Date:  2015-03-25       Impact factor: 3.402

Review 3.  Polymeric oncolytic adenovirus for cancer gene therapy.

Authors:  Joung-Woo Choi; Young Sook Lee; Chae-Ok Yun; Sung Wan Kim
Journal:  J Control Release       Date:  2015-10-23       Impact factor: 9.776

Review 4.  Prospective therapies for high-grade glial tumours: A literature review.

Authors:  Sayed Samed Talibi; Sayed Samie Talibi; Bashaar Aweid; Osama Aweid
Journal:  Ann Med Surg (Lond)       Date:  2014-05-21

Review 5.  Imaging in gene therapy of patients with glioma.

Authors:  A H Jacobs; J Voges; L W Kracht; C Dittmar; A Winkeler; A Thomas; K Wienhard; K Herholz; W D Heiss
Journal:  J Neurooncol       Date:  2003-12       Impact factor: 4.506

6.  Trial watch: Oncolytic viruses for cancer therapy.

Authors:  Erika Vacchelli; Alexander Eggermont; Catherine Sautès-Fridman; Jérôme Galon; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2013-04-16       Impact factor: 8.110
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.